Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
69,300
+38,914
+128% +$1.02M 1.18% 13
2026
Q1
$853K Buy
+30,386
New +$809K 0.42% 76
2025
Q3
Sell
-36,818
Closed -$892K 773
2025
Q2
$892K Buy
36,818
+15,236
+71% +$355K 0.2% 175
2025
Q1
$547K Sell
21,582
-845
-4% -$22.1K 0.27% 120
2024
Q4
$595K Buy
+22,427
New +$608K 0.44% 76
2024
Q3
Sell
-34,313
Closed -$960K 376
2024
Q2
$960K Buy
+34,313
New +$945K 0.72% 28
2023
Q4
Sell
-26,981
Closed -$895K 317
2023
Q3
$895K Buy
26,981
+19,957
+284% +$706K 0.57% 61
2023
Q2
$258K Sell
7,024
-9,943
-59% -$387K 0.23% 155
2023
Q1
$692K Buy
+16,967
New +$733K 0.88% 38

Other funds holding PFE

iSAM Funds (UK)'s PFE Position: Q2 2026 in Review

iSAM Funds (UK) increased its Pfizer (PFE) stake by 128% in Q2 2026, buying an estimated $1.02M and bringing the position to 69,300 shares worth $1.67M. The position accounts for 1.18% of the portfolio, ranked #13.

iSAM Funds (UK) first reported a position in PFE in Q1 2023 and has held it in 9 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • iSAM Funds (UK) held 69,300 shares of Pfizer worth $1.67M as of Q2 2026.
  • iSAM Funds (UK) bought 38,914 Pfizer shares in Q2 2026, an estimated $1.02M.
  • Pfizer made up 1.18% of iSAM Funds (UK)'s portfolio in Q2 2026, its #13 holding.
  • iSAM Funds (UK) first reported a position in Pfizer in Q1 2023 and has held it in 9 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on iSAM Funds (UK)'s 13F filing for Q2 2026, filed 12 Aug 2026.